Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H

By Tebbey P.W.   Scheuer C.A.   Peek J.A.   Zhu D.   LaPierre N.A.   Green B.A.   Phillips E.D.   Ibraghimov A.R.   Eldridge J.H.   Hancock G.E.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2723-2734

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Adjuvant effect of cholera toxin on systemic and mucosal immune responses in chickens infected with E. tenella or given recombinant parasitic antigen per os

By Girard F.   Pery P.   Naciri M.   Quere P.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1516-1524

Elsevier

Access to resources Recommend Favorite

Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice

By Li T.-C.   Takeda N.   Miyamura T.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3476-3484

Elsevier

Access to resources Recommend Favorite

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

By Moldoveanu Z.   Clements M.L.   Prince S.J.   Murphy B.R.   Mestecky J.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1006-1012

Elsevier

Access to resources Recommend Favorite